NEW SPIROINDANE DERIVATIVE HAVING RSK1 INHIBITION

Title:

NEW SPIROINDANE DERIVATIVE HAVING RSK1 INHIBITION

Document Type and Number:

Japanese Patent JP2009173629

Kind Code:

A

Abstract:

To provide a new compound which inhibits the multiplication of tumor cells on the basis of RSK1 inhibition and exhibits an antitumor effect, a pharmaceutical composition comprising the compound, an RSK1 inhibitor, and an anticancer agent.

The compound of the formula is a representative example of new spiroindane derivatives, and the pharmaceutical composition, the RSK1 inhibitor, and the anticancer agent comprise the compound.

More Like This:

WO/2020/200209	AROMATIC AMINE COMPOUND AND USE THEREOF IN PREPARATION OF AR AND BRD4 DUAL INHIBITORS AND REGULATORS
WO/2019/169183	AMYLOID PROTEIN-SELECTIVE BACE INHIBITORS (ASBIS) FOR ALZHEIMER'S DISEASE
JP2005503376	Indazole or indole derivatives and their use in human medicine, more specifically in the treatment of cancer

Inventors:

ASAKAWA KENICHI
HASHIMOTO MASAYA
ITO HIROKATSU
NAKAMURA MASAYUKI
NONOSHITA KATSUMASA
OKUBO MITSURU
SATO ATSUSHI
TAKAHASHI HIROBUMI

Application Number:

JP2008271313A

Publication Date:

August 06, 2009

Filing Date:

October 21, 2008

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BANYU PHARMA CO LTD

International Classes:

C07D413/04; A61K31/4245; A61K31/427; A61K31/433; A61K31/4355; A61K31/437; A61K31/438; A61K31/4439; A61K31/454; A61P35/00; A61P43/00; C07D413/14; C07D417/14; C07D471/04; C07D491/107; C07D519/00

Previous Patent: OXALIC ACID DERIVATIVE AND ITS USE AS PHYSIOLOGICAL COOLING ACTIVE INGREDIENT

Next Patent: LIPID ABSORPTION INHIBITOR CONTAINING POLY--GLUTAMIC ACID